Patent · US Active

Scaffolds and multifunctional intermediates for imaging PSMA and cancer therapy

US10736974B2 · kind B2 · utility

4Cited by
1References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 22, 2015
Grant dateAug 11, 2020
Priority date
Expiry dateOct 22, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K49/0019
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Carbamate and beta-amino acid urea-based scaffolds that have high binding affinity to PSMA are disclosed. These scaffolds can be radiolabeled and used for imaging cells and tumors that express PSMA or for cancer radiotherapy. These compounds also can comprise a fluorescent dye and be used for imaging cells and tumors that express PSMA or for photodynamic therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.